Norwegian Military Academy

Election to Equinor's board of directors

Retrieved on: 
Wednesday, November 30, 2022

On 30 November 2022 the corporate assembly of Equinor ASA (OSE:EQNR, NYSE:EQNR) elected Haakon Bruun-Hanssen as new member to Equinor ASAs board of directors.

Key Points: 
  • On 30 November 2022 the corporate assembly of Equinor ASA (OSE:EQNR, NYSE:EQNR) elected Haakon Bruun-Hanssen as new member to Equinor ASAs board of directors.
  • Haakon Bruun-Hanssen is elected as a new shareholder-elected member of the board of directors, replacing Bjrn Tore Godal.
  • He is also educated at Military Command and Staff college, Instituut Defensie Leergangen in The Netherlands and has participated in work sessions relating to board roles and tasks at Insead In-Board Nordic Academy.
  • The election enters into effect from 12 December 2022 and is effective until the ordinary election of shareholder-elected members to the board of directors in 2023.

Recommendation from Equinor's nomination committee

Retrieved on: 
Wednesday, November 23, 2022

The nomination committee in Equinor ASA (OSE:EQNR, NYSE:EQNR) recommends that the company's corporate assembly elects Haakon Bruun-Hanssen as new member to Equinor ASAs board of directors.

Key Points: 
  • The nomination committee in Equinor ASA (OSE:EQNR, NYSE:EQNR) recommends that the company's corporate assembly elects Haakon Bruun-Hanssen as new member to Equinor ASAs board of directors.
  • Board member Bjrn Tore Godal, who has been a member since 2010, wishes to step down from his position as board member and the nomination committee recommends Haakon Bruun-Hanssen as shareholder-elected member of the board of directors.
  • The election to Equinor's board of directors takes place in the company's corporate assembly meeting Wednesday 30 November 2022.
  • All enquiries to be directed through Equinor Corporate Press Office, Sissel Rinde, +47 412 60 584

Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors

Retrieved on: 
Monday, December 6, 2021

OSLO, Norway and LONDON, Dec. 6, 2021 /PRNewswire/ -- Exact Therapeutics AS ("EXACT-Tx", or "the Company" Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today is delighted to announce the appointment of Anders Wold to its Board of Directors.

Key Points: 
  • Anders Wold has nearly forty years of leadership experience in the healthcare and ultrasound industry.
  • He grew the GE Healthcare Cardiovascular Ultrasound business from US$50 million to US$500 million in sales by 2008.
  • Dr Masha Strmme, Executive Chair of the Board, stated:"We are delighted to welcome Anders Wold to our Board.
  • Anders Wold, Director of the Board, stated: "I am excited to be joining the EXACT Therapeutics Board.

Exact Therapeutics AS Appoints Prominent Ultrasound And Healthcare Expert To Its Board Of Directors

Retrieved on: 
Monday, December 6, 2021

Anders Wold has nearly forty years of leadership experience in the healthcare and ultrasound industry.

Key Points: 
  • Anders Wold has nearly forty years of leadership experience in the healthcare and ultrasound industry.
  • He grew the GE Healthcare Cardiovascular Ultrasound business from US$50 million to US$500 million in sales by 2008.
  • Dr Masha Strmme, Executive Chair of the Board, stated:"We are delighted to welcome Anders Wold to our Board.
  • Anders Wold, Director of the Board, stated: "I am excited to be joining the EXACT Therapeutics Board.